Summary
XBI Chart
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006.
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
The SPDR S&P Biotech ETF (XBI) was launched on 01/31/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006.
SPDR S&P Biotech ETF Dividends
 XBI 5 months ago Paid | Quarterly | $0 Per Share |
| XBI 8 months ago Paid | Quarterly | $0.01 Per Share |
| XBI 11 months ago Paid | Quarterly | $0.12 Per Share |
| XBI 18 Dec 2023 Paid | Quarterly | $0.01 Per Share |
| XBI 20 Jun 2023 Paid | Quarterly | $0 Per Share |
SPDR S&P Biotech ETF Earnings
| XBI 5 months ago Paid | Quarterly | $0 Per Share |
| XBI 8 months ago Paid | Quarterly | $0.01 Per Share |
| XBI 11 months ago Paid | Quarterly | $0.12 Per Share |
| XBI 18 Dec 2023 Paid | Quarterly | $0.01 Per Share |
| XBI 20 Jun 2023 Paid | Quarterly | $0 Per Share |
SPDR S&P Biotech ETF (XBI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has SPDR S&P Biotech ETF ever had a stock split?
SPDR S&P Biotech ETF Profile
| ARCA Exchange | US Country |
Overview
The provided company is a financial entity that focuses on mirroring the performance of the S&P Biotechnology Select Industry Index. By employing a sampling strategy, the fund aims to invest predominantly, if not entirely, in the components that make up the index. This index is a representation of the biotechnology segment of the S&P Total Market Index (S&P TMI), encompassing companies within the biotechnology industry. The strategy includes investing at least 80% of its total assets in the securities that form part of the index, ensuring a strong alignment with the biotechnology sector's market movements.
Products and Services
- Biotechnology Industry Index Fund
This product is designed for investors seeking exposure to the biotechnology sector. The fund tracks the S&P Biotechnology Select Industry Index, which is a subset of the larger S&P Total Market Index (S&P TMI) focused specifically on the biotechnology industry. By putting a significant portion of its assets—substantially all, but at a minimum, 80%—into the securities that compose the index, the fund offers a direct pathway for investment in a diversified portfolio of biotechnology companies. The sampling strategy employed aims to replicate the index's performance, making it an attractive option for those looking to invest in the biotechnology industry through a mechanism that mirrors its market dynamics closely.
Contact Information
